1599478-70-2

Basic information

• Product Name: 2-(3-(2-chloro-5-(trifluoromethoxy)phenyl)-8-methyl-3-azaspiro[5.5]undecan-9-yl)acetic acid
• Synonyms: 2-(3-(2-chloro-5-(trifluoromethoxy)phenyl)-8-methyl-3-azaspiro[5.5]undecan-9-yl)acetic acid
• CAS NO: 1599478-70-2
• Molecular Weight: 419.872
• Mol File: 1599478-70-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-(3-(2-chloro-5-(trifluoromethoxy)phenyl)-8-methyl-3-azaspiro[5.5]undecan-9-yl)acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3-(2-chloro-5-(trifluoromethoxy)phenyl)-8-methyl-3-azaspiro[5.5]undecan-9-yl)acetic acid(1599478-70-2)
• EPA Substance Registry System: 2-(3-(2-chloro-5-(trifluoromethoxy)phenyl)-8-methyl-3-azaspiro[5.5]undecan-9-yl)acetic acid(1599478-70-2)

Safety Data

• Hazardous Substances Data: 1599478-70-2(Hazardous Substances Data)

Upstream product

• 1599479-13-6 ethyl 2-(3-(2-chloro-5-(trifluoromethoxy)phenyl)-8-methyl-3-azaspiro[5.5]undecan-9-yl)acetate 
• 1599479-12-5 ethyl 2-(8-methyl-3-azaspiro[5.5]undecan-9-yl)acetate 
• 1056629-20-9 3-azaspiro[5.5]undecane-3-carboxylic acid, 9-oxo, phenylmethyl ester 
• 1599479-09-0 benzyl 8-methyl-9-oxo-3-azaspiro[5.5]undecane-3-carboxylate 

Relevant articles and documents

SUBSTITUTED SPIROPIPERIDINYL COMPOUNDS USEFUL AS GPR120 AGONISTS

The present invention relates to a compound represented by formula (I): and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing diabetes, hyperlipidemia, obesity, inflammation related disorders, and related diseases and conditions. The compounds are useful as agonists of the G-protein coupled receptor GPR120. Pharmaceutical compositions and methods of treatment are also included.